Intellia Therapeutics (NTLA) EBITDA Margin Growth (5y) (2020 - 2026)
Intellia Therapeutics (NTLA) EBITDA Margin Growth (5y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Intellia Therapeutics |
1.86 Bn |
1.86 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
6,917.00 |
| Dec 31, 2025 |
22,424.00 |
| Sep 30, 2025 |
-60,690.00 |
| Jun 30, 2025 |
-51,312.00 |
| Mar 31, 2025 |
-5,101.00 |
| Dec 31, 2024 |
-76,289.00 |
| Sep 30, 2024 |
-121,881.00 |
| Jun 30, 2024 |
-188,637.00 |
| Mar 31, 2024 |
-16,468.00 |
| Dec 31, 2023 |
706,792.00 |
| Sep 30, 2023 |
-71,029.00 |
| Jun 30, 2023 |
-62,915.00 |
| Mar 31, 2023 |
-49,420.00 |
| Dec 31, 2022 |
-45,083.00 |
| Sep 30, 2022 |
-63,517.00 |
| Jun 30, 2022 |
-45,753.00 |
| Mar 31, 2022 |
-114,522.00 |
| Dec 31, 2021 |
-45,880.00 |
| Sep 30, 2021 |
-2.38 Mn |
| Jun 30, 2021 |
-88,534.00 |
